Anika Therapeutics Correlations

ANIK Stock  USD 16.99  0.29  1.68%   
The current 90-days correlation between Anika Therapeutics and Axogen Inc is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anika Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anika Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Anika Therapeutics Correlation With Market

Good diversification

The correlation between Anika Therapeutics and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.

Moving together with Anika Stock

  0.68JNJ Johnson JohnsonPairCorr
  0.74LLY Eli Lilly Earnings Call This WeekPairCorr
  0.67UPC Universe PharmaceuticalsPairCorr
  0.61ENSG Ensign GroupPairCorr
  0.67ACHC Acadia HealthcarePairCorr

Moving against Anika Stock

  0.6BMY Bristol Myers Squibb Earnings Call This WeekPairCorr
  0.44EHAB EnhabitPairCorr
  0.41GILD Gilead Sciences Earnings Call This WeekPairCorr
  0.4ALTS ALT5 Sigma Symbol ChangePairCorr
  0.39SEM Select Medical HoldingsPairCorr
  0.38LFCR Lifecore BiomedicalPairCorr
  0.64V Visa Class APairCorr
  0.61MTZ MasTec IncPairCorr
  0.6PLTR Palantir Technologies Earnings Call This WeekPairCorr
  0.5GILT Gilat Satellite NetworksPairCorr
  0.44LPTH LightPath Technologies Earnings Call This WeekPairCorr
  0.38NRG NRG EnergyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NPCEFNA
AVNSSGHT
NPCEAORT
AORTAXGN
NPCEAXGN
CVRXAORT
  
High negative correlations   
SGHTFNA
NPCESGHT
NPCEAVNS
AVNSFNA
SGHTAORT
AVNSAXGN

Risk-Adjusted Indicators

There is a big difference between Anika Stock performing well and Anika Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Anika Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
AXGN  2.83  0.59  0.12 (1.81) 3.50 
 5.35 
 21.20 
OFIX  1.44  0.21  0.09  0.48  1.69 
 3.14 
 12.11 
SRDX  0.75 (0.11) 0.00 (1.77) 0.00 
 1.68 
 9.34 
FNA  3.14  1.67  0.61 (9.12) 1.53 
 7.83 
 43.16 
AORT  1.37  0.23  0.10  0.75  1.38 
 3.49 
 9.51 
SGHT  2.80 (0.76) 0.00  2.74  0.00 
 6.65 
 17.90 
AVNS  1.91 (0.45) 0.00 (0.24) 0.00 
 3.95 
 19.15 
KIDS  2.48 (0.13) 0.00 (0.04) 0.00 
 4.85 
 16.22 
NPCE  3.82  1.36  0.36  1.98  2.85 
 9.73 
 35.79 
CVRX  3.57  0.85  0.19  1.52  3.42 
 7.38 
 41.08 

Anika Therapeutics Corporate Management

Ian McLeodVP OfficerProfile
James ChaseSenior MarketingProfile
Bart BracyVP AmericasProfile
Lisa FunicielloVice ResourcesProfile
Mark NamaroffExecutive CommunicationsProfile
Michael CPAExecutive OfficerProfile
Charles IIIVP CounselProfile